Elevian Company
Elevian develops medicines that restore youthful regenerative capacity, with the potential to treat and prevent many age-related diseases.
Technology:
Regenerative Medicine
Industry:
Biopharma, Biotechnology
Headquarters:
Allston, Massachusetts, United States
Founded Date:
2017
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
9
Total Funding:
24333889
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020
Last Funding Type:
Seed
Register and Claim Ownership